the balanced life semaglutide Living Your Healthiest by Summer Kessel | Quarto At A Glance Decoding GLP-1 Weight Loss Medications

Cost Considerations : The high cost of brand-name medications can deter patients from seeking treatment

With semaglutide patents set to expire in 2026, Indian drugmakers are preparing to enter the market with generics

A maintenance plan before stopping treatment can help reduce the risk of weight regain

Scientific Reference (Gut Barrier + Akkermansia): Everard A

Exclusivity & Patent Protection: Currently, Semaglutide GLP-1 is under patent protection, which can keep prices higher until generic or biosimilar alternatives become available

This innovation addresses a long-standing barrier in obesity care: the reliance on injectable therapies